Search results for "Coronavirus"


 
Results 1 - 10 of about 271 for "Coronavirus".
Sort by: Relevance | Newest | Oldest

Biomarkers may predict which medications are effective for patients hospitalized for COVID-19

Two studies looked at biomarkers that could be used to identify high-risk hospital patients who would likely benefit from medications for COVID-19, while another recent analysis provided reassuring data on the aftereffects of acute kidney injury during COVID-19 hospitalization.
https://acphospitalist.acponline.org/archives/2024/02/28/free/biomarkers-may-predict-which-medications-are-effective-for-patients-hospitalized-for-covid-19.htm
28 Feb 2024

Latest COVID-19 trials show convalescent plasma worked, vitamin C did not

A trial of high-titer convalescent plasma in COVID-19 patients recently put on mechanical ventilation found an improvement in mortality, while another study showed that IV vitamin C did not help and might have harmed patients.
https://acphospitalist.acponline.org/archives/2023/11/01/free/latest-covid-19-trials-show-convalescent-plasma-worked-vitamin-c-did-not.htm
1 Nov 2023

Fungal infection common in critically ill COVID-19 patients

A retrospective study in Belgium found that risk of pulmonary aspergillosis in mechanically ventilated COVID-19 patients was primarily associated with pre-existing risk factors for invasive mold disease.
https://acphospitalist.acponline.org/archives/2023/09/20/free/fungal-infection-common-in-critically-ill-covid-19-patients.htm
20 Sep 2023

Elevated risk of hospitalization, death after COVID-19 dwindles by six months

A hospitalization for COVID-19 carries higher mortality risk than one for flu for only 90 days, one study found, while another showed that veterans who had COVID-19 actually had lower mortality risk than matched uninfected peers in the subsequent six months to two years.
https://acphospitalist.acponline.org/archives/2023/08/23/free/elevated-risk-of-hospitalization-death-after-covid-19-dwindles-by-six-months.htm
23 Aug 2023

Chest physicians make 11 recommendations on antithrombotic therapy in COVID-19

The recommendations on prevention and management of arterial thrombosis and thromboembolism are not a major departure from prepandemic ones, according to an expert panel from the American College of Chest Physicians.
https://acphospitalist.acponline.org/archives/2023/07/05/free/chest-physicians-make-11-recommendations-on-antithrombotic-therapy-in-covid-19.htm
5 Jul 2023

At a year, after-effects of COVID-19 hospitalization other than VTE similar to flu, sepsis

Compared to patients hospitalized with flu or sepsis, those with COVID-19 had increased risk of venous thromboembolism (VTE), stroke, depression, and anxiety in the 30 days after discharge, but over a year, only the risk for VTE was significantly elevated.
https://acphospitalist.acponline.org/archives/2023/06/28/free/at-a-year-after-effects-of-covid-19-hospitalization-other-than-vte-similar-to-flu-sepsis.htm
28 Jun 2023

Higher risk of false-positive HIV test in those testing positive for COVID-19 infection

Hospitalized patients with positive SARS-CoV-2 polymerase chain reaction (PCR) test results were significantly more likely to have a false-positive fourth-generation HIV test than those with negative SARS-CoV-2 PCR test results, a retrospective study found.
https://acphospitalist.acponline.org/archives/2023/05/24/free/higher-risk-of-false-positive-hiv-test-in-those-testing-positive-for-covid-19-infection.htm
24 May 2023

Procalcitonin algorithm reduced antibiotic use in COVID-19 inpatients

A Dutch intervention used procalcitonin levels in inpatients with COVID-19 to guide antibiotic use, with an algorithm discouraging prescriptions if levels were less than 0.25 ng/mL and recommending antibiotics for patients with levels above 0.5 ng/mL.
https://acphospitalist.acponline.org/archives/2023/05/03/free/procalcitonin-algorithm-reduced-antibiotic-use-in-covid-19-inpatients.htm
3 May 2023

Sepsis scores perform poorly in COVID-19 patients, study finds

In the latest COVID-19 news, a retrospective analysis tested common inpatient risk scores using data from patients who presented to EDs early in the pandemic, and the FDA authorized additional boosters for older and immunocompromised patients.
https://acphospitalist.acponline.org/archives/2023/04/26/free/sepsis-scores-perform-poorly-in-covid-19-patients-study-finds.htm
26 Apr 2023

No benefit found from high-dose steroids, RAS inhibitors in latest COVID-19 trials

Multiple new studies tested renin-angiotensin system (RAS) inhibitors in inpatients with COVID-19, while the latest report from the RECOVERY trial found higher mortality in patients on no or regular oxygen who received high-dose corticosteroids compared to usual care.
https://acphospitalist.acponline.org/archives/2023/04/19/free/no-benefit-found-from-high-dose-steroids-ras-inhibitors-in-latest-covid-19-trials.htm
19 Apr 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next